Vireo Growth Inc. (VREOF)
OTCMKTS · Delayed Price · Currency is USD
0.5200
+0.0190 (3.79%)
Jul 29, 2025, 4:00 PM EDT
Vireo Growth Market Cap
Vireo Growth has a market cap or net worth of $490.51 million as of July 29, 2025. Its market cap has increased by 689.01% in one year.
Market Cap
490.51M
Enterprise Value
494.48M
Revenue
99.84M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.52
Market Cap Chart
Since March 20, 2019, Vireo Growth's market cap has increased from 296.29M to 490.51M, an increase of 65.55%. That is a compound annual growth rate of 8.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 499.50M | 141.74% |
| Dec 31, 2024 | 206.63M | 498.26% |
| Dec 29, 2023 | 34.54M | 69.69% |
| Dec 30, 2022 | 20.35M | -90.69% |
| Dec 31, 2021 | 218.67M | 51.51% |
| Dec 31, 2020 | 144.33M | 59.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 590.95M |
| Glass House Brands | 435.80M |
| Northwest Biotherapeutics | 377.68M |
| CytoDyn | 371.09M |